T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors

T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors

Background: Plasma circulating tumor deoxyribonucleic acid (ctDNA) test is an alternative method to detect the T790M mutation. Compared to conventional tumor rebiopsy, ctDNA possesses several advantages including less invasive, faster, lower costs, and having minimal risk of complications for patien...

Full description

Bibliographic Details
Main Authors: Vinodini Merinda, Gatot Soegiarto, Laksmi Wulandari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Lung India
Subjects:
t790m mutation
first-line epidermal growth factor receptor-tyrosine kinase inhibitors
lung adenocarcinoma
plasma circulating tumor deoxyribonucleic acid
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=1;spage=13;epage=18;aulast=Merinda

Similar Items

Similar Items